Showing results (361-370 of 2,132) with videos related to
Sort By:
Pageof 214
Biopharmaceutics & Drug Disposition|March 1, 1994
Bioavailability and reversible metabolism of prednisone and prednisolone in manV Garg, W J JuskoBiopharmaceutics & Drug Disposition|August 1, 1994
The penetration of amphotericin B from an Intralipid formulation into fibrin loci in a rabbit model of candidiasisM Bouley, M Tod, P Chavanet, et al.Biopharmaceutics & Drug Disposition|August 1, 1994
Relative bioavailability of four controlled-release nifedipine productsR Schall, F O Müller, H K Hundt, et al.Biopharmaceutics & Drug Disposition|August 1, 1994
The influence of food on the disposition of the antiepileptic oxcarbazepine and its major metabolites in healthy volunteersP H Degen, G Flesch, J M Cardot, et al.Biopharmaceutics & Drug Disposition|July 1, 1994
The pharmacokinetics of methotrexate after intravenous administration of methotrexate-loaded proliposomes to ratsJ M Park, B N Ahn, E J Yoon, et al.Biopharmaceutics & Drug Disposition|July 1, 1994
The effect of oral dose volume on the absorption of a highly and a poorly water-soluble drug in the ratD F Nickerson, M L Weaver, F L TseBiopharmaceutics & Drug Disposition|November 1, 1994
The pharmacokinetics and absolute bioavailability of selegiline in the dogI Mahmood, D K Peters, W D MasonBiopharmaceutics & Drug Disposition|December 1, 1994
Variable gastric emptying and discontinuities in drug absorption profiles: dependence of rates and extent of cimetidine absorption on motility phase and pHP Langguth, K M Lee, H Spahn-Langguth, et al.Biopharmaceutics & Drug Disposition|December 1, 1994
Griseofulvin absorption from different sites in the human small intestineT GramattéBiopharmaceutics & Drug Disposition|April 5, 2002
Absence of clinically relevant drug interactions following simultaneous administration of didanosine-encapsulated, enteric-coated bead formulation with either itraconazole or fluconazoleB Damle, H Hess, S Kaul, et al.Pageof 214